Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > HLA-G

HLA-G

Brief Information

Name:HLA class I histocompatibility antigen, alpha chain G
Target Synonym:HLA G antigen,MHC class I antigen G,sHLA-G
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:6
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
HLG-H51H3 Human Human HLA-G protein, His Tag
HLG-H51H3-structure
HLG-H51H3-sds
ACRO Quality

Part of Bioactivity data

HLG-H51H3-MALS-HPLC
 HLA-G ELISA

Immobilized Human HLA-G protein, His Tag (Cat. No. HLG-H51H3) at 5 μg/mL (100 μL/well) can bind Human KIR2DL4, Fc Tag (Cat. No. KI4-H5255) with a linear range of 1.6-50 ng/mL (QC tested).

Synonym Name

HLA-G, HLA class I histocompatibility antigen, alpha chain G, HLAG, HLA-6.0

Background

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
CAR-001 CAR-001; CAR001; CAR BiTE γδT; CD3ε Nb-BiTE; Nb-CAR.BiTE-γδT PD-L1 Phase 2 Clinical Ever Supreme Bio Technology Co Ltd Solid tumours Details
UCB4594 UCB4594; UCB-4594 Phase 2 Clinical Ucb Sa Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Carcinoma, Renal Cell; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Colorectal Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung Details
CARGo - Anti - HLA-G CAR-T Cell Therapy(MD Anderson Cancer Center) Phase 2 Clinical The University Of Texas MD Anderson Cancer Center Solid tumours Details
IVS-3001 IVS-3001 Phase 2 Clinical Invectys Solid tumours Details
JNJ-78306358 JNJ-78306358; JNJ-6358 Phase 1 Clinical Janssen Research & Development Llc Solid tumours Details
TTX-080 TTX-080; TTX080 Phase 1 Clinical Tizona Therapeutics Inc Solid tumours; Neoplasms Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message